Etude USTEKINISU : A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU)
Contact: Philip Bielefeld, philip.bielefeld@chu-dijon.fr
Mis à jour le 24 juillet 2020
